Clinuvel Pharmaceuticals Ltd SEC filings CUVL

Clinuvel Pharmaceuticals Ltd has 49 filings in SEC EDGAR's recent list, going back to May 7, 2004. Its latest annual report, Form 20-F, was filed on Oct 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on June 30.

Clinuvel Pharmaceuticals Ltd SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 30, 2026 Oct 30, 2026
6-K Current report (foreign issuer) Oct 15, 2026 Oct 15, 2026
6-K Current report (foreign issuer) Oct 7, 2026 Oct 7, 2026
6-K Current report (foreign issuer) Oct 2, 2026 Oct 2, 2026
6-K Current report (foreign issuer) Oct 1, 2026 Oct 1, 2026
6-K Current report (foreign issuer) Sep 9, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Aug 27, 2026 Aug 27, 2026
6-K Current report (foreign issuer) Aug 20, 2026 Aug 20, 2026
6-K Current report (foreign issuer) Aug 12, 2026 Aug 12, 2026
6-K Current report (foreign issuer) Jul 30, 2026 Jul 30, 2026
6-K Current report (foreign issuer) Jul 28, 2026 Jul 28, 2026
6-K Current report (foreign issuer) Jul 27, 2026 Jul 27, 2026
6-K Current report (foreign issuer) Jul 23, 2026 Jul 23, 2026
6-K Current report (foreign issuer) Jul 22, 2026 Jul 21, 2026
6-K Current report (foreign issuer) Jul 22, 2026 Jul 21, 2026

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
American Depositary Receipts (SIC 8880)
Listed as
CUVL (Nasdaq), CLVLF (OTC)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Melbourne, Victoria
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1290877
Former names
EpiTan LTD (until Mar 20, 2006)

Other American Depositary Receipts companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.